Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD

Clinical trial NCT06757504 · RECRUITING

Trial details

NCT number: NCT06757504
Sponsor: Shanghai Auzone Biological Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder (ASD)

Start date: 2025-01-13
Primary completion: 2026-02-06
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.